Article thumbnail

Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis

By M. Knüppel, S. Kubicka, A. Vogel, N. P. Malek, M. Schneider, F. Papendorf, T. Greten, J. Wedemeyer and A. Schneider


Background. Due to the predominantly advanced stage at the time of diagnosis treatment of cholangiocarcinoma is difficult. Apart from surgical resection, interventional treatment strategies are increasingly used in advanced stage tumours. The aim of the study was a retrospective comparison of the effect of the various forms of treatment on morbidity and mortality. Method. A total of 195 patients, received either chemotherapy or a combination of photodynamic therapy (PDT) or transarterial chemoembolization (TACE) and chemotherapy. Results. The median survival rate for all patients was 15.6 months, 50.8% were still alive 1 year after diagnosis. Patients, who had previously undergone surgery, survived 17.1 months longer than those without surgical treatment (P < .01). Chemotherapy prolonged the survival by 9.2 months (P = .47). Palliative patients under combination of chemotherapy and PDT survived on average 1.8 months longer (P = .28), with chemotherapy and TACE 9.8 months longer (P = .04) compared to chemotherapy alone. Conclusions. It appears that surgical treatment and chemotherapy combined with PDT or TACE may prolong survival

Topics: Clinical Study
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2003). a l k a ,V .B o i g e ,C .D r o m a i n ,T .D e b a e r e ,M .P o c a r d ,a n d M. Ducreux, “Biliary tract neoplasms: update
  2. (2004). A review and update on cholangiocarcinoma,”
  3. (2003). A spotlight on cholangiocarcinoma,”
  4. (1965). Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features,”
  5. (1995). B.Glimelius,K.Hoffman,W.Grafetal.,“Cost-effectivenessof palliative chemotherapy in advanced gastrointestinal cancer,”
  6. (2003). Biliary tract neoplasms: update
  7. (2007). Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials,”
  8. (2010). Cholangiocarcinoma: a position paper by the Italian Society
  9. (2004). Cholangiozellul¨ ares Karzinom und
  10. (2001). Endoscopic application of photodynamic therapy for cholangiocarcinoma,”
  11. (2000). Hepatobiliary surgery,”
  12. Initial experience fromacombinationofsystemicandregionalchemotherapyin the treatment of patients with nonresectable cholangiocellular carcinoma in the liver,”
  13. (2002). Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma,”
  14. (2002). K h a n ,S .D .T a y l o r - R o b i n s o n ,M .B .T o l e d a n o ,A .B e c k
  15. (1989). n g ,a n dT .L .H w a n g , “Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma,”
  16. (2008). o n a s ,T
  17. (2005). Palliation of nonresectable bile duct cancer: improved survival after photodynamictherapy,”TheAmericanJournalofGastroenterology,
  18. (2003). Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma,”
  19. (2004). Photodymic therapy in patients with non-resectable hilar cholangiocarcinoma: 5— yearfollow-upofaprospectivephaseIIstudy,”Gastrointestinal Endoscopy,
  20. (2001). Photodynamic therapy for cholangiocarcinoma,” Journal of Hepato-Biliary-Pancreatic Surgery,v o l .8 ,n o .2 ,p p .
  21. (1998). Photodynamic therapy of nonresectable cholangiocarcinoma,”
  22. (1991). Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report,”
  23. (2005). Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma,”
  24. (2005). Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapyforadvancedbileductcancerandtheroleofintraductal ultrasonography in response assessment,”
  25. (2007). Risk factors for cholangiocarcinoma,”
  26. (2002). S.A.Khan,B.R.Davidson,R.Goldinetal.,“Guidelinesforthe diagnosis and treatment of cholangiocarcinoma: consensus document,”
  27. (1996). Sj¨ od´ en et al., “Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer,”
  28. (2003). Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study,”
  29. (1992). Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than 5 years,”
  30. (2000). Tannapfel et al., “Photodynamic therapy for advanced bile duct cancer: evidence for improved palliationandextendedsurvival,”Hepatology,vol.31,pp.291– 298,
  31. (2005). Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.